NCT07912151Not yet recruiting
Dynamic Stabilometry Combined With Transcranial Direct Current Stimulation for Balance and Motor Recovery After Ischemic Stroke
Efficacy of Combined Dynamic Stabilometry and Transcranial Electrical Stimulation in the Early Recovery Period of Ischemic Stroke in Patients With Hemiparesis: a Single-Center Randomized Study
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if balance training on a moving (dynamic) platform with visual and sound feedback, combined with weak electrical brain stimulation, helps people recover balance and movement after an ischemic stroke with weakness on one side of the body (hemiparesis). The main questions it aims to answer are: * Does the combination of dynamic platform training and active brain stimulation improve balance more than either method alone? * Does it improve independence in daily activities, mobility and walking, and reduce fall risk? * Is the combined treatment safe in the early period after stroke? Researchers will compare four groups: dynamic platform training with active stimulation, dynamic platform training with sham (imitation) stimulation, training on a locked (static) platform with active stimulation, and training on a locked platform with sham stimulation. Participants will: * Receive standard rehabilitation (exercise therapy and physiotherapy) of the same volume in all groups. * Complete 10 sessions of 20-minute platform training over 12 days (5 sessions per week), with active or sham brain stimulation during each session. * Have balance, mobility and neurological tests on Day 0, Day 6 and Day 12.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 27 Oct 2026
- Start date
- 28 Oct 2026
- Primary completion date
- 28 Dec 2026
- Lead sponsor
- Samara State Medical University
- Diseases
- Stroke
- NCT number
- NCT07912151
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 28 Oct 2026 to the primary completion date, 28 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severe concomitant orthopedic disorders preventing verticalization
Other illness
- Hemorrhagic stroke
- History of epilepsy or seizures
- Intracranial metal implants or cardiac pacemaker
- Marked vestibular dysfunction (Meniere's disease, benign paroxysmal positional vertigo in exacerbation)
- Severe visual impairment preventing use of visual biofeedback
- Unstable somatic condition (heart failure NYHA class III-IV, unstable angina, blood pressure \> 180/110 mm Hg)
- Recurrent stroke within the last 3 months
- Scalp diseases in the electrode placement areas
Other
- Severe aphasia preventing understanding of instructions
- Severe lower limb spasticity (Modified Ashworth Scale ≥ 3)
- MMSE score \< 20
Who the study is looking for
- Ischemic stroke verified by neuroimaging (computed tomography or magnetic resonance imaging)
- Mild or moderate hemiparesis
- Time since stroke onset from 7 days to 6 months
- Ability to stand with support for at least 30 seconds
- Age 30 to 85 years
- Mini-Mental State Examination (MMSE) score ≥ 20
- Medical stability (no acute somatic complications)
- Signed informed consent
Age in the registry: 30 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samara City Clinical Hospital No. 2 named after N.A. Semashko Coordinator of this site? Confirm its status | Samara | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.